LISATA THERAPEUTICS INC. - COMMON STOCK

Lisata Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

08 май 2025 16:05:02 Источник Nasdaq GlobeNewswire

Lisata Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update on Thursday, May 8, 2025

01 май 2025 08:00:00 Источник Nasdaq GlobeNewswire

Lisata Therapeutics Announces Research License with Catalent

15 апр 2025 08:00:00 Источник Nasdaq GlobeNewswire

Lisata Therapeutics to Present at the Investival Showcase USA

06 мар 2025 08:30:00 Источник Nasdaq GlobeNewswire

Lisata Therapeutics and GATC Health Consummate First Step in Strategic Collaboration to use AI to Derisk and Accelerate Drug Development

05 мар 2025 08:30:00 Источник Nasdaq GlobeNewswire

Lisata Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

27 фев 2025 16:05:00 Источник Nasdaq GlobeNewswire

Lisata Therapeutics to Report Full Year 2024 Financial Results and Provide a Business Update on Thursday, February 27, 2025

20 фев 2025 08:00:00 Источник Nasdaq GlobeNewswire

Lisata Therapeutics to Present at the 2025 BIO CEO & Investor Conference

05 фев 2025 08:30:00 Источник Nasdaq GlobeNewswire

Lisata Therapeutics and WARPNINE Announce Encouraging Preliminary Results from the Phase 1b/2a iLSTA Trial Evaluating Certepetide in Locally Advanced Non-Resectable Pancreatic Ductal Adenocarcinoma

23 янв 2025 08:00:00 Источник Nasdaq GlobeNewswire

Lisata Therapeutics Reports Encouraging Preliminary Cohort A Data from the AGITG-led Phase 2 ASCEND Trial Evaluating Certepetide with Standard-of-Care Chemotherapy in Metastatic Pancreatic Ductal Adenocarcinoma

22 янв 2025 08:00:00 Источник Nasdaq GlobeNewswire

Lisata Therapeutics to Present at the 2025 Sequire Investor Summit

15 янв 2025 08:30:00 Источник Nasdaq GlobeNewswire

Lisata Therapeutics Announces Completion of Enrollment in the CENDIFOX Trial

10 дек 2024 08:30:00 Источник Nasdaq GlobeNewswire

Lisata Therapeutics and Kuva Labs Announce Global License Agreement for Solid Tumor Imaging

03 дек 2024 08:30:00 Источник Nasdaq GlobeNewswire

Lisata Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

12 ноя 2024 16:05:01 Источник Nasdaq GlobeNewswire

Lisata Therapeutics and Valo Therapeutics Announce Preclinical Research Collaboration

06 ноя 2024 09:23:21 Источник Nasdaq GlobeNewswire

Lisata Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update on Tuesday, November 12, 2024

06 ноя 2024 08:30:00 Источник Nasdaq GlobeNewswire

Lisata Therapeutics to Participate in Upcoming November 2024 Industry and Investor Events

31 окт 2024 08:30:00 Источник Nasdaq GlobeNewswire

Lisata Therapeutics Announces Sponsored Preclinical Research Agreement with the University of Cincinnati to Study Certepetide for the Treatment of Endometriosis

28 окт 2024 08:30:00 Источник Nasdaq GlobeNewswire

Lisata Therapeutics to Participate in Upcoming October 2024 Industry and Investor Events

03 окт 2024 08:00:00 Источник Nasdaq GlobeNewswire

Lisata Therapeutics Announces First Patient Treated in the Second-line Cholangiocarcinoma Cohort of the BOLSTER Trial

17 сен 2024 08:00:00 Источник Nasdaq GlobeNewswire